Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Cipher Pharmaceuticals ( (TSE:CPH) ) has provided an announcement.
Cipher Pharmaceuticals announced it will release its Q4 and fiscal 2024 financial results on March 18, 2025, followed by a conference call on March 19, 2025, to discuss the results and corporate developments. This announcement is significant for stakeholders as it provides insights into the company’s financial health and strategic direction, potentially impacting its market positioning and investor relations.
More about Cipher Pharmaceuticals
Cipher Pharmaceuticals is a specialty pharmaceutical company with a diverse portfolio of commercial and developmental products, primarily in dermatology. The company focuses on acquiring products that address unmet medical needs, managing clinical development and regulatory approvals, and marketing these products in Canada, the U.S., and South America.
YTD Price Performance: -22.99%
Average Trading Volume: 17,881
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $193.7M
For detailed information about CPH stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue